NOXXON Pharma AG
31Patents
27Active
31Granted
51Portfolio score
Filing activity: May 25, 2001 → Nov 30, 2017 · 9 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6534271B2 | Cloning and copying on surfaces | Emerging Cross-Sectional Technologies | 25 | Expired |
| US7879991B2 | CGRP binding nucleic acids | Chemistry; Metallurgy | 21 | Expired |
| US7629456B2 | Modified L-nucleic acid | Chemistry; Metallurgy | 14 | Expired |
| US8871920B2 | Lipid binding nucleic acids | Chemistry; Metallurgy | 6 | Active |
| US9976145B2 | Nucleic acid molecule having binding affinity to a target molecule and a method for generating the same | Physics | 6 | Active |
| US9518265B2 | C5a binding nucleic acids | Physics | 6 | Active |
| US8507456B2 | C5a binding nucleic acids | Emerging Cross-Sectional Technologies | 6 | Active |
| US7750140B2 | Ghrelin binding nucleic acids | Chemistry; Metallurgy | 6 | Expired |
| US8314223B2 | SDF-1 binding nucleic acids | Chemistry; Metallurgy | 5 | Active |
| US8772257B2 | SDF-1 binding nucleic acids and the use thereof | Emerging Cross-Sectional Technologies | 4 | Active |
| US8193159B2 | MCP-1 binding nucleic acids | Chemistry; Metallurgy | 3 | Active |
| US8367629B2 | MCP-1 binding nucleic acids and use thereof | Human Necessities | 3 | Active |
| US8841431B2 | Hepcidin binding nucleic acids | Physics | 3 | Active |
| US9387221B2 | SDF-1 binding nucleic acids and the use thereof in cancer treatment | Chemistry; Metallurgy | 2 | Active |
| US9163243B2 | Nucleic acids specifically binding CGRP | Chemistry; Metallurgy | 2 | Active |
| US8497250B2 | Use of spiegelmers to inhibit an intracellular target molecule | Physics | 2 | Active |
| US9850471B2 | Enzymatic synthesis of L-nucleic acids | Chemistry; Metallurgy | 2 | Active |
| US9035038B2 | SDF-1 binding nucleic acids | Chemistry; Metallurgy | 1 | Active |
| US10093934B2 | SDF-1 binding nucleic acids and the use thereof in cancer treatment | Chemistry; Metallurgy | 1 | Active |
| US8383789B2 | Vasopressin-binding L-nucleic acid | Chemistry; Metallurgy | 0 | Active |
| US11459352B2 | Method for polyalkoxylation of nucleic acids that enables recovery and reuse of excess polyalkoxylation reagent | Emerging Cross-Sectional Technologies | 0 | Active |
| US9074214B2 | Use of spiegelmers | Physics | 0 | Active |
| US10273480B2 | MCP-1 binding nucleic acids | Chemistry; Metallurgy | 0 | Active |
| US8101734B2 | Ghrelin binding nucleic acids | Chemistry; Metallurgy | 0 | Active |
| US10590424B2 | C5a binding nucleic acids | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.